Objectives: The aim of this study was to achieve an understanding what determines the attitude of people toward complementary and alternative medicine (CAM) is essential in decisions about costly therapies in cancer treatment. Design: This study involved population-based surveys conducted in 1995 and 2005. Setting: In 1995 and 2005, a quota sample of 2400 Austrians ages !15 was selected and invited in writing to participate in a survey to study beliefs and attitudes about cancer, its risk factors, and treatment. The sample comprised 0.04% of the population !15 years of age and was representative in terms of age, sex, occupational status, and area of residence. Subjects: The subjects included 4073 Austrian adults (2073 participants enrolled in the 1995 survey and 2000 participants of the 2005 survey). Intervention: Respondents were visited in their homes by trained interviewers. The interview was face-to-face, using a standardized questionnaire. Outcome measures: We used a dichotomized variable as the outcome, placing high value on CAM (rated as 1 or 2 on a 5-level Likert scale) versus everything else (rated 3-5). Results: Positive personal experiences with people cured of cancer improved the likelihood of a positive perception of CAM (odds ratio [OR], 1.36; 95% confidence interval [CI], 1.17-1.59 for those who reported knowing someone who was cured of cancer, compared to those who did not). In multivariate models adjusting for personal attitude toward mainstream medicine, subjects with more formal education were also more likely to believe that CAM is valuable (OR, 1.28; 95% CI, 1.02-1.61), as were women (OR, 1.40; 95% CI, 1.20-1.64) and people ages 70 and above (OR, 1.46; 95% CI, 1.02-2.08). A higher appreciation of mainstream medicine was inversely associated with the value placed on CAM in cancer therapy (OR, 0.43; 95% CI,. Conclusions: In this, to our knowledge, the first study to evaluate predictors of CAM preference in cancer treatment in a national probability sample, we found more formal education, female gender, and older age to be the strongest predictors of a person favoring CAM therapy in cancer treatment. Our data also suggest that people who are satisfied with conventional care were less inclined to value CAM, whereas a positive personal experience with cancer cures improved positive perception of CAM.
Introduction

C
ancer remains one of the main causes of death worldwide, 1,2 including Austria. 3 Mainstream cancer therapy modalities include chemotherapy, surgery, and radiation, as well as hormone therapy and immunotherapy. Besides these scientifically validated therapy modalities, complementary and alternative medicine (CAM), which is widely used in the United States and Europe 4,5 particularly among women, 6 has also gained increasing recognition in cancer treatment. While no uniform definition of CAM exists, 7 CAM therapies largely include therapy forms that have not been validated in a standard fashion. In one of the earliest studies describing the prevalence of CAM in the United States, Eisenberg defined alternative medicine as ''medical interventions not taught widely at U.S. medical schools or generally available at United States hospitals.'' 8 Most commonly, CAM, as opposed to mainstream medicine, is understood as meaning unorthodox or nonstandard treatment forms. 9 We will use the term CAM similarly throughout this article, referring to therapies that have not been formally accepted specifically into clinical cancer care.
Despite the widespread use of CAM, 5, 8, 10 factors that determine the value placed on them by individuals in cancer treatment are poorly understood. A large U.S. study based on data from the 2002 National Health Interview Survey suggested that healthier risk profiles and behaviors are associated with more widespread use of CAM. 11 Previous evaluations, most notably a study of 1035 randomly selected individuals in the United States, 12 also suggested that education and poorer health status are the strongest predictors of the general use of alternative medicine. How and whether this also applies to CAM use in cancer therapy is not wellunderstood.
To evaluate factors that influence attitudes towards cancer therapy, particularly CAM cancer therapy, we studied a large representative sample of Austrians. The country's health system includes statutory health insurance with close to 100% population coverage, and Austria is one of the most affluent countries in the world. 13 
Materials and Methods
The data analyzed were extracted from the populationbased cross-sectional study Attitudes Towards Cancer, which was conducted twice, in September 1995 and August 2005. Funded by the Austrian Cancer Society, each of the surveys comprehensively covered Austria (2005 population, 8.17 million; 6.85 million !15 years of age; 1.77 million men and 1.92 million women 40-79 years old). A quota sample of Austrians age !15 was preselected, representative with regard to age, sex, occupational status, and area of residence. The aim of these two surveys was to examine knowledge, attitudes, and behavior regarding various aspects of cancer. Selection criteria, sample size, methods, and questionnaires were identical in 1995 and 2005. [14] [15] [16] [17] Study population and survey instrument For both surveys, in cooperation with a public opinion survey institute, a quota sample of 2400 Austrians ages !15 years was selected and invited in writing to participate in a survey to study beliefs and attitudes about cancer, its risk factors, and treatment. The sample comprised 0.04% of the population !15 years of age and was representative in terms of age, sex, occupational status, and area of residence. In September 1995 and August 2005, respondents were visited in their homes by trained interviewers. The interview was face-to-face, using a standardized questionnaire.
Of the 2400 planned interviews, only 86.4% and 83.3%, respectively, were completed because the subjects were either not at home or refused the interview. The remaining interviewees met the inclusion criteria regarding representativeness. For validation purposes, 30% of the interviews were repeated by telephone, and no significant differences from the original face-to-face interviews were found. Specifically, the survey questions involved perception of cancer cure (''Do you believe that cancer can be cured?'' and ''Do you know someone who was cured of cancer?''), as well as knowledge and value placed on various cancer treatment methods (''What value do you place on the following treatment modalities in cancer therapy: Chemotherapy, surgery, radiation, hormonal therapy, immune therapy, and complementary medicine, including miracle healing?''), using the 5-level Likert scale with ''1'' considered ''most valuable.'' In addition to eliciting specific information on beliefs and attitudes about cancer genesis and prevention, data on sociodemographic variables (age, sex, marital status, residence, education, and income) were also collected. A relatively large proportion of participants chose not to disclose information about their employment status and income, and we therefore did not use this information in our analyses.
Statistical analysis
The sample of respondents was weighted by age (poststratified) to the Austrian census population in 2001. Frequencies and 95% confidence limits were calculated by the SURVEYFREQ procedure in SAS. The chi-square distribution was used to test the significance of the difference between the two time periods (1995 and 2005). P-values were two-sided, and values 0.05 were considered statistically significant. For multivariate analyses, the SURVEYLOGIS-TIC procedure in SAS was used, using a dichotomized variable as the outcome, placing high value on CAM (rated as 1 or 2 on the 5-level Likert scale) versus everything else (rated 3-5). All statistical analyses were performed using SAS v.9.1 (SAS Institute, Cary, NC).
Results
We had valid data for 2073 participants enrolled in the 1995 survey and 2,000 participants of the 2005 survey. Demographic factors were largely comparable between the two surveys. The differences were modest and reflected expected trends in demographics (Table 1) . For example, in 2005, participants were slightly more likely to live in single households and less likely to be married than in 1995. General education appeared to improve over time, with fewer people reporting having completed only primary school (21.5% in 2005 versus 29.5% in 1995).
Overall, we observed a trend towards a more positive attitude regarding the curability of cancer over time. The proportion of participants reporting knowing someone who was cured of cancer rose from 51.2% in 1995 to 55.7% in 2005, an increase paralleled by more participants believing that cancer could be cured most of the time (57.2% in 1995 versus 64.1% in 2005) ( Table 2) .
When asked to score the value they placed on a number of cancer treatment modalities including more traditional modalities (chemotherapy, surgery, radiation, and hormonal therapy, and immune therapy) as well as CAM, participants scored surgery and chemotherapy highest, with little difference between 1995 and 2005.
Next, we constructed a multivariate prediction model to evaluate which factors contributed to whether a person placed high value on CAM ( Mean score AE standard deviation on a scale from 1 to 5, with 1 indicative of highest value, and 5 indicative of little value placed on the respective treatment modality; excludes those who answered ''don't know.'' CAM, complementary and alternative medicine.
Discussion
We studied determinants of attitudes about cancer therapy in the Austrian population, where everyone benefits from a mandatory health insurance system providing a wide range of free screening and other preventive services. To our knowledge, ours is the first study to examine predictors of attitudes about CAM in cancer therapy over time, with two independent assessments in 1995 and 2005. Overall, we found female sex, older age, and more formal education to be the strongest predictors of a person favoring CAM therapy in cancer treatment.
To date, the most comprehensive study to evaluate reasons for a person's decision to use CAM in a broader health context was conducted in the United States, and comprised a national sample of 1035 individuals who were queried on their habitual use of CAM and a number of possible predictors for CAM use. 12 Astin identified a number of important predictors of alternative health care use in that study: poorer health status (OR, 1.3; 95% CI, 1.1-1.5); higher level of education (OR, 1.2; 95% CI, 1.1-1.3); and a holistic orientation to health (OR, 1.4; 95% CI, 1.1-1.9). Interestingly, dissatisfaction with mainstream medicine did not predict the use of CAM in this random selection of Americans. Similarly, CAM use was studied among 1001 German adults: The strongest predictors for CAM use in this population-based telephone survey were female sex (OR 2.32, 95% CI, 1.74-3.08) and a higher level of education (OR, 3.25; 95% CI, 1.35-7.81). 18 A study evaluated attitudes, use, and information-seeking behavior regarding CAM among 677 medical students, interns, and faculty in the United States, designed to assess the need for future CAM instruction in medical school and residency. 19 The authors described a more positive attitude and higher use of CAM modalities among the faculty, compared to students; however, no other data on potential predictors of these associations were reported.
Few studies have examined preferences in cancer treatment, and they do not provide a comprehensive report of predictors for CAM preference. The use of a wide range of CAM treatment modalities, overall, is modestly higher among patients with cancer compared to the general population. 20, 21 In Germany, a retrospective evaluation among 1063 children who survived cancer demonstrated a high prevalence (up to 35%) of CAM use, with higher social status and poorer prognosis of the child's disease most strongly predicting parents' preference for CAM use. 22 Moreover, parents' preference for CAM seemed to influence the choice of CAM treatment modalities significantly for children with cancer. 23 CAM use is also widespread among European adult patients with cancer (36%) 24 particularly among Italians (73%): In a study of 132 patients with cancer, 17% reported CAM use after diagnosis; female sex and higher education were the strongest predictors for CAM use in this small study. 25 In line with the larger prevalence of general CAM use among women, 6 a large European study also showed CAM use is much more prevalent among female patients with cancer. 26 Furthermore, the high prevalence of CAM use among women with a genetic predisposition to develop cancer seems to parallel that of patients with cancer. 27 However, as studies from Shanghai, Japan, Taiwan, and Nigeria suggest, CAM use in cancer treatment may vary widely, probably depending on the cultural background of the patient. [28] [29] [30] [31] In addition, preliminary data suggest that cultural differences exist in the preference of oncologists to prescribe CAM. 32 Depression and pain have been associated with a preference for CAM in 725 U.S. women with cancer, 33 though a prior study of 251 Canadian patients with breast cancer suggested a heightened awareness of the risk of death or recurrence, rather than anxiety or depression, more strongly predicted CAM use. 34 Finally, a large survey of 1844 cancer survivors reported that the likelihood of patients using CAM treatment modalities increased with decreasing degrees of religiosity. 35 Our finding that women, and people with a higher education level, place a higher value on CAM in cancer treatment are in line with prior findings regarding predictors for CAM CAM (complementary and alternative medicine) preference defined as scores 1 or 2 (highly valued) compared to scores 3-5 (less valued). All models are mutually adjusted for age; gender; survey year; education (less formal education: primary school, apprentice ship, or secondary school without diploma, versus more formal education: secondary school with diploma or university education); value placed on orthodox medicine (i.e., chemotherapy, surgery, radiation, hormonal therapy, or immune therapy); whether believes in cure (always, almost always, or frequently vs. rarely or never); and whether knows someone cured (yes versus no).
Results shown as odds ratios (OR) and 95% confidence intervals (CI).
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use in general health care. 12,18 While Astin did not find that overall dissatisfaction with mainstream medicine predicted use of CAM, the small proportion of individuals (5%) who relied primarily on alternative health care did report more dissatisfaction with standard care. We too found an inverse association between the value placed on standard and CAM treatment modalities in our study.
A number of limitations may have hampered our study results and should be noted. For example, a large number of participants chose not to disclose information about their employment status and income, and we were therefore unable to explore the role of these variables in the observed associations. However, with close to 100% population coverage for health insurance and unemployment benefits, these factors were likely to play a smaller role in Austria as compared to other, less affluent, countries. Another limitation is the cross-sectional design of this study, not allowing us to determine the direction of potential causal relationships. For example, whether a preference for CAM determines the value placed on standard treatment modalities or vice versa is not possible to sort out with our data. However, demographics such as age, sex, and educational status are plausible predictors for CAM preference.
The strengths of our study include the socioeconomic structure of Austria, which, due to its affluence and universal health care system, reduces the likelihood of a potential underrepresentation of less affluent or less healthy participants. Our response rates (83% and 86%, respectively) also eliminate any major concerns for selection bias.
Conclusions
Our results demonstrate a number of significant predictors for preference of CAM in cancer treatment in Austria. We found more formal education, female sex, and older age to be the strongest predictors of a person favoring CAM therapy in cancer treatment in this national probability sample. These findings may aid health care providers in sensibly addressing the needs and concerns regarding CAM treatment modalities of their patients.
